BlackRock Fund Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $82M | Buy |
|
|||||
|
2016
Q3 | $102M | Buy |
|
|||||
|
2016
Q2 | $88.4M | Sell |
|
|||||
|
2016
Q1 | $127M | Buy |
|
|||||
|
2015
Q4 | $179M | Sell |
|
|||||
|
2015
Q3 | $133M | Buy |
|
|||||
|
2015
Q2 | $152M | Sell |
|
|||||
|
2015
Q1 | $129M | Buy |
|
|||||
|
2014
Q4 | $63.7M | Buy |
|
|||||
|
2014
Q3 | $40.1M | Sell |
|
|||||
|
2014
Q2 | $38.2M | Sell |
|
|||||
|
2014
Q1 | $45.2M | Buy |
|
|||||
|
2013
Q4 | $22.6M | Sell |
|
|||||
|
2013
Q3 | $27.8M | Buy |
|
|||||
|
2013
Q2 | $28.5M | Buy |
|